(Q35889915)

10 August 2017

Outcomes and prognostic factors in modern era management of major salivary gland cancer (English)

1 reference

10 August 2017

4

Kelly R Magliocca

1 reference

10 August 2017

Naresh Jegadeesh

1

1 reference

10 August 2017

Yuan Liu

2

1 reference

10 August 2017

Roshan S Prabhu

3

1 reference

10 August 2017

David M Marcus

5

1 reference

10 August 2017

Kristin A Higgins

6

1 reference

10 August 2017

Jeffrey M Vainshtein

7

1 reference

10 August 2017

J Trad Wadsworth

8

1 reference

10 August 2017

Jonathan J Beitler

9

1 reference

10 August 2017

language of work or name

English

0 references

publication date

29 May 2015

1 reference

10 August 2017

1 reference

10 August 2017

51

1 reference

10 August 2017

8

1 reference

10 August 2017

770-777

1 reference

Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515354

Diagnostic and therapeutic implications of new molecular biomarkers in salivary gland cancers

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515354

Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515354

Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United States.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515354

Outcomes of postoperative concurrent chemoradiotherapy for locally advanced major salivary gland carcinoma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515354

Salivary gland cancers: current treatments, molecular characteristics and new therapies

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515354

Postoperative and primary radiotherapy for salivary gland carcinomas: indications, techniques, and results

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515354

Systemic therapy in the palliative management of advanced salivary gland cancers.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515354

Postoperative radiotherapy for malignant tumors of the parotid gland.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515354

Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515354

Activity of chemotherapy in the palliative treatment of salivary gland tumors: review of the literature

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515354

Local-regional recurrence after surgery without postoperative irradiation for carcinomas of the major salivary glands: implications for adjuvant therapy

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515354

Phase II trial of taxol in salivary gland malignancies (E1394): a trial of the Eastern Cooperative Oncology Group

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515354

Malignant parotid tumors: presentation, clinical/pathologic prognostic factors, and treatment outcomes

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515354

Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515354

Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515354

Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515354

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515354

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515354

Cancer of the Parotid Gland: Role of 7th Nerve Preservation

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515354

Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515354

Herceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II study

6 December 2018

1 reference

12 December 2020

Salivary gland tumours. A review of 2410 cases with particular reference to histological types, site, age and sex distribution.

1 reference

12 December 2020

Carcinoma of the salivary gland: a clinicopathologic study of 405 cases

1 reference

12 December 2020

Malignant tumors of major salivary gland origin. A matched-pair analysis of the role of combined surgery and postoperative radiotherapy

1 reference

12 December 2020

Radiotherapy alone or combined with surgery for salivary gland carcinoma

1 reference

12 December 2020

Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study

1 reference

12 December 2020

10.1016/J.ORALONCOLOGY.2015.05.005

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

26033470

1 reference